IPS IMAT- Instituto Medico de Alta Tecnologia - Oncomedica S.A.

Montería 230002

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, First Line Non-Small Cell Lung Cancer

Studies at this site

• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed